Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

GSK Licenses Late-stage Antibiotic from Spero Therapeutics (2022-09-22)
> The exclusive licence allows GSK to commercialise tebipenem HBr in all regions except for Japan and certain other Asian countries > Spero Therapeutics receives $66 million upfront, with potential for future milestone payments and tiered royalties > GSK to p...
Merck Opens € 29m Biologics Testing Center in Shanghai (2022-09-21)
> First-of-its-kind facility for Merck in China to meet local demand > New lab marks completion of phase 1 of company’s new Biologics Testing Center > Phase 2 to include expansion of cell line characterization and lot release testing services Merck, a le...
Tridek-One Closes a €16 M Round Led by Pureos Bioventures (2022-09-15)
> Financing led by Pureos Bioventures with significant participation from new and historical investors > Funds will primarily be used to identify candidates to develop, conduct IND-enabling studies and further build the organization > Tridek-One also appointe...
SparingVision Raises €75m Series B Financing (2022-09-14)
> Proceeds to fund first-in-human trials of breakthrough gene therapy products, SPVN06 and SPVN20, and advance CRISPR-based genome editing portfolio in collaboration with Intellia Therapeutics > Series B was co-led by Jeito Capital and UPMC Enterprises, with par...
Pretzel Therapeutics Launches with $72.5m Series A Financing (2022-09-12)
> Company to leverage expertise in mitochondrial biology to advance novel treatments for both rare and common diseases > Pretzel founded by leading academic experts in mitochondrial biology and backed by world-class investor syndicate > Platform technologies...
AAVantgarde Bio Appoints Natalia Misciattelli as CEO (2022-09-08)
AAVantgarde Bio, a clinical stage Milan-based international biotechnology start-up that has developed proprietary Adeno-Associated Viral (AAV) vector platforms that allow for the delivery of large genes for inherited retinal disorders, announced the appointment of ...
PhoreMost: Drug Target Discovery Collaboration with Roche (2022-09-06)
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a multi-...
Nodus Oncology Launches with Seed Funding & Partner LDC (2022-09-06)
Newly appointed CEO, Ian Waddell PhD, will lead the discovery and preclinical development of Nodus Oncology’s DDR-focused pipeline and will be supported by a team including Luis Toledo, PhD, Scientific Founder and Advisor Nodus Oncology, a novel biotech compan...
Nodus Oncology Acquires Basilea’s PARG Inhibitor Programme (2022-09-06)
Acquisition enables Nodus Oncology to continue building its portfolio of first and best-in-class molecules inhibiting novel DNA damage response targets (DDR) Nodus Oncology (“Nodus” or “the Company”), a novel biotech company focused on developing first and bes...
Pleco Therapeutics Announces Final Series A Close at €17.3m (2022-09-06)
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment today announces the final close of its Series A financing, with total funds raised of €17.3 million. The funds will be used to...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Made Without Love 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)